Cassava Sciences

Cassava CEO, ‘dazed and confused’, takes to biotech defense handbook by blaming short sellers for woes
Fierce Biotech
Fri, 09/3/21 - 11:18 am
Cassava Sciences
FDA
Alzheimer's disease
Cassava's stock tumbles again, after Quanterix said it 'did not' prepare data charts presented by Cassava, that are under dispute
Marketwatch
Fri, 08/27/21 - 10:46 am
Quanterix
Cassava Sciences
Alzheimer's disease
Here's Why Cassava Sciences Is Having a Bad Day
Motley Fool
Wed, 08/25/21 - 12:19 pm
Cassava Sciences
FDA
citizen petitions
simufilam
Here's What Investors Should Know About Cassava's Alzheimer's Drug Candidate
Motley Fool
Thu, 08/12/21 - 12:11 am
Cassava Sciences
Alzheimer's disease
simufilam
Biden's Budget May Boost These 3 Biotechs
Motley Fool
Mon, 05/10/21 - 09:31 pm
Joe Biden
Alzheimer's disease
Denali Therapeutics
Cassava Sciences
Eli Lilly
Biogen's Possible Shopping List: 3 Companies the Biotech Might Buy
Motley Fool
Wed, 11/11/20 - 11:01 am
Biogen
M&A
Aurinia
Cassava Sciences
Heron Therapeutics
Cassava Sciences Announces Positive Results In Phase 2 Trial Of New Alzheimer’s Drug
Forbes
Mon, 09/14/20 - 10:25 am
Cassava Sciences
clinical trials
Alzheimer's disease
sumifilam
The Week Ahead In Biotech: ASH 2019 Gets Underway, Biogen's Aducanumab Data And More
Yahoo/Benzinga
Mon, 12/2/19 - 09:42 am
ASH2019
Roche
Bristol-Myers Squibb
Acadia Pharmaceuticals
Biogen
Cassava Sciences
Alector
GW Pharma
Magenta Therapeutics
Fortress Biotech
Mustang Bio
Bluebird Bio

Pages